Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Inherited Loss of Samsn1 Contributes to Increased Risk of MGUS and MM through Effects on Multiple Cell Types, Including B-Cells, Transformed Myeloma Cells, and Macrophages

Sarah Amend, PhD, William C Wilson, PhD, Liang Chu, PhD, Daniel Serie, PhD, Celine M Vachon, PhD, Lan Lu, MSci, Xinming Su, PhD, Michelle A Hurchla, Dingyan Wang, PhD, Pengyuan Liu, PhD, Ravi Vij, MD, Graham A Colditz, MD, Dr.PH., Katherine N Weilbaecher, MD, Michael H. Tomasson, MD

Blood (2014) 124 (21): 2075.

https://doi.org/10.1182/blood.V124.21.2075.2075

Published: 2014

Journal Articles

Preclinical Development Of a Nanomedicne Approach For Multiple Myeloma Targeting The Myc Oncoprotein

Deepti Soodgupta, PhD, Dipanjan Pan, PhD, Grace Hu, MS, Angana Senpan, PhD, Xiaoxia Yang, BS, Katherine N Weilbaecher, MD, Edward V. Prochownik, MD, PhD, Gregory M Lanza, MD, PhD, Michael H Tomasson, MD

Blood (2013) 122 (21): 4228.

https://doi.org/10.1182/blood.V122.21.4228.4228

Published: 2013

Journal Articles

Zoledronic Acid Improves Overall Survival Compared To Pamidronate In Multiple Myeloma

Kristen M. Sanfilippo, MD, Brian F Gage, MD, MSc, Suhong Luo, MPH, Ravi Vij, MD, Michael H. Tomasson, MD, Katherine N Weilbaecher, MD, Kenneth R. Carson, MD

Blood (2013) 122 (21): 3182.

https://doi.org/10.1182/blood.V122.21.3182.3182

Published: 2013

Journal Articles

Deletion Of Samsn1 Underlies Genetic Susceptibility To Monoclonal Gammopathy Of Undetermined Significance (MGUS) In Mice

Sarah Amend, B.S., Liang Chu, PhD, Daniel Serie, PhD, Celine M Vachon, PhD, Lan Lu, MSci, Ravi Vij, MD, Graham A Colditz, M.D., Dr.PH., Katherine N Weilbaecher, MD, Michael H. Tomasson, MD

Blood (2013) 122 (21): 397.

https://doi.org/10.1182/blood.V122.21.397.397

Published: 2013

Journal Articles

Epoxyketone-Based Proteasome Inhibitors Carfilzomib and Orally Bioavailable ONX 0912 Have Anti-Resorptive and Bone-Anabolic Activity in Addition to Anti-Myeloma Effects

Michelle A Hurchla, Antonio Garcia-Gomez, Mary C Hornick, Enrique M Ocio, Aixiao Li, Juan F Blanco, Lynne Collins, Christopher J Kirk, David Piwnica-Worms, Ravi Vij, MD, Michael H Tomasson, Atanasio Pandiella, Jesús F San Miguel, Mercedes Garayoa, Katherine N Weilbaecher

Blood (2011) 118 (21): 2906.

https://doi.org/10.1182/blood.V118.21.2906.2906

Published: 2011

NARROW

Inherited Loss of Samsn1 Contributes to Increased Risk of MGUS and MM through Effects on Multiple Cell Types, Including B-Cells, Transformed Myeloma Cells, and Macrophages

Preclinical Development Of a Nanomedicne Approach For Multiple Myeloma Targeting The Myc Oncoprotein

Zoledronic Acid Improves Overall Survival Compared To Pamidronate In Multiple Myeloma

Deletion Of Samsn1 Underlies Genetic Susceptibility To Monoclonal Gammopathy Of Undetermined Significance (MGUS) In Mice

Epoxyketone-Based Proteasome Inhibitors Carfilzomib and Orally Bioavailable ONX 0912 Have Anti-Resorptive and Bone-Anabolic Activity in Addition to Anti-Myeloma Effects

Email alerts

ASH Publications

American Society of Hematology

Inherited Loss of Samsn1 Contributes to Increased Risk of MGUS and MM through Effects on Multiple Cell Types, Including B-Cells, Transformed Myeloma Cells, and Macrophages

Preclinical Development Of a Nanomedicne Approach For Multiple Myeloma Targeting The Myc Oncoprotein

Zoledronic Acid Improves Overall Survival Compared To Pamidronate In Multiple Myeloma

Deletion Of Samsn1 Underlies Genetic Susceptibility To Monoclonal Gammopathy Of Undetermined Significance (MGUS) In Mice

Epoxyketone-Based Proteasome Inhibitors Carfilzomib and Orally Bioavailable ONX 0912 Have Anti-Resorptive and Bone-Anabolic Activity in Addition to Anti-Myeloma Effects

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only